Modular Medical, Inc. (MODD)
USD 0.89
(-8.75%)
USD 0.89
(-8.75%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -8.04 Million USD | -256.77% |
| 2023 | -2.25 Million USD | 74.65% |
| 2022 | -8.89 Million USD | -761.76% |
| 2021 | 1.34 Million USD | 147.13% |
| 2020 | -2.85 Million USD | 56.5% |
| 2019 | -6.55 Million USD | -52.55% |
| 2018 | -4.29 Million USD | -217.96% |
| 2017 | -1.35 Million USD | -1130.68% |
| 2016 | 131.09 Thousand USD | 8.85% |
| 2015 | 120.42 Thousand USD | 20.11% |
| 2014 | 100.26 Thousand USD | 10.13% |
| 2013 | 91.04 Thousand USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 100.0% |
| 2004 | -76.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -8.04 Million USD | -256.77% |
| 2024 Q3 | -770 Thousand USD | 84.51% |
| 2024 Q1 | -8.51 Million USD | -277.66% |
| 2024 Q2 | -4.97 Million USD | 41.61% |
| 2024 Q4 | -8.04 Million USD | -944.42% |
| 2023 FY | -2.25 Million USD | 74.65% |
| 2023 Q2 | -10.72 Million USD | 20.82% |
| 2023 Q1 | -13.54 Million USD | -52.36% |
| 2023 Q4 | -2.25 Million USD | 70.39% |
| 2023 Q3 | -7.61 Million USD | 29.02% |
| 2022 Q4 | -8.89 Million USD | -227.05% |
| 2022 FY | -8.89 Million USD | -761.76% |
| 2022 Q3 | 6.99 Million USD | 62.53% |
| 2022 Q2 | 4.3 Million USD | 239.52% |
| 2022 Q1 | 1.26 Million USD | -5.61% |
| 2021 Q2 | -647.32 Thousand USD | 71.11% |
| 2021 FY | 1.34 Million USD | 147.13% |
| 2021 Q4 | 1.34 Million USD | 645.3% |
| 2021 Q3 | 180.28 Thousand USD | 127.85% |
| 2021 Q1 | -2.24 Million USD | 21.43% |
| 2020 Q4 | -2.85 Million USD | 23.32% |
| 2020 FY | -2.85 Million USD | 56.5% |
| 2020 Q1 | -5.7 Million USD | 12.93% |
| 2020 Q2 | -4.77 Million USD | 16.31% |
| 2020 Q3 | -3.71 Million USD | 22.14% |
| 2019 Q2 | -3.68 Million USD | 9.03% |
| 2019 Q3 | -7.13 Million USD | -93.55% |
| 2019 FY | -6.55 Million USD | -52.55% |
| 2019 Q4 | -6.55 Million USD | 8.18% |
| 2019 Q1 | -4.05 Million USD | 5.64% |
| 2018 Q2 | -4.76 Million USD | -247.38% |
| 2018 FY | -4.29 Million USD | -217.96% |
| 2018 Q1 | -1.37 Million USD | -270.17% |
| 2018 Q3 | -4.51 Million USD | 5.4% |
| 2018 Q4 | -4.29 Million USD | 4.74% |
| 2017 FY | -1.35 Million USD | -1130.68% |
| 2017 Q4 | -370.75 Thousand USD | -361.11% |
| 2017 Q3 | 141.98 Thousand USD | 1.57% |
| 2017 Q2 | 139.79 Thousand USD | 6.64% |
| 2017 Q1 | 131.09 Thousand USD | 1.36% |
| 2016 FY | 131.09 Thousand USD | 8.85% |
| 2016 Q4 | 129.33 Thousand USD | 1.68% |
| 2016 Q2 | 121.2 Thousand USD | 0.64% |
| 2016 Q3 | 127.19 Thousand USD | 4.94% |
| 2016 Q1 | 120.42 Thousand USD | 1.47% |
| 2015 Q2 | 102.23 Thousand USD | 1.97% |
| 2015 FY | 120.42 Thousand USD | 20.11% |
| 2015 Q1 | 100.26 Thousand USD | 0.19% |
| 2015 Q4 | 118.68 Thousand USD | 1.93% |
| 2015 Q3 | 116.44 Thousand USD | 13.9% |
| 2014 Q4 | 100.07 Thousand USD | 2.2% |
| 2014 Q1 | 91.04 Thousand USD | 0.0% |
| 2014 Q2 | 95.02 Thousand USD | 4.37% |
| 2014 FY | 100.26 Thousand USD | 10.13% |
| 2014 Q3 | 97.92 Thousand USD | 3.05% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | 91.04 Thousand USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | 100.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 Q3 | -76.00 USD | 0.0% |
| 2005 Q4 | -76.00 USD | 0.0% |
| 2005 Q2 | -76.00 USD | 0.0% |
| 2005 FY | - USD | 100.0% |
| 2004 FY | -76.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 129.695% |
| BrainsWay Ltd. | -10.32 Million USD | 22.074% |
| Cerus Corporation | 84.35 Million USD | 109.534% |
| Envoy Medical, Inc. | -3.81 Million USD | -110.855% |
| electroCore, Inc. | -9.95 Million USD | 19.216% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -56.917% |
| IceCure Medical Ltd | -9.93 Million USD | 19.046% |
| Inogen, Inc. | -103.56 Million USD | 92.235% |
| OrthoPediatrics Corp. | -9.26 Million USD | 13.219% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -120.873% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 38.597% |
| MaxCyte, Inc. | -27.76 Million USD | 71.033% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -56.517% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -1296.746% |
| Orthofix Medical Inc. | 96.44 Million USD | 108.339% |
| PAVmed Inc | 29.08 Million USD | 127.649% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 52.524% |
| RxSight, Inc. | -6.68 Million USD | -20.389% |
| Sight Sciences, Inc. | -102.71 Million USD | 92.171% |
| SI-BONE, Inc. | 5.72 Million USD | 240.57% |
| TELA Bio, Inc. | -3.94 Million USD | -103.646% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 114.03% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 2384.659% |
| Acutus Medical, Inc. | 12.27 Million USD | 165.494% |
| Talis Biomedical Corporation | -57.06 Million USD | 85.907% |
| Spectral AI, Inc. | -3.5 Million USD | -129.706% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 83.255% |
| CVRx, Inc. | -59.95 Million USD | 86.587% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 505.313% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 729.443% |
| Bioventus Inc. | 372.51 Million USD | 102.159% |
| Venus Concept Inc. | 74.3 Million USD | 110.824% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 21.017% |
| LivaNova PLC | 62.53 Million USD | 112.861% |
| 908 Devices Inc. | -115.09 Million USD | 93.013% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 102.508% |
| Nemaura Medical Inc. | 9.92 Million USD | 181.028% |
| NeuroPace, Inc. | 54.33 Million USD | 114.8% |
| LENSAR, Inc. | -18.31 Million USD | 56.083% |
| Apyx Medical Corporation | -5.15 Million USD | -56.125% |
| Cutera, Inc. | 288.3 Million USD | 102.789% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 207.013% |
| BioSig Technologies, Inc. | 262 Thousand USD | 3169.466% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 81.652% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 12.577% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 100.572% |
| Axonics, Inc. | -77.19 Million USD | 89.582% |
| Outset Medical, Inc. | 67.67 Million USD | 111.883% |
| IRIDEX Corporation | -4.28 Million USD | -87.547% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 95.482% |
| IRadimed Corporation | -47.71 Million USD | 83.147% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -165.763% |
| INVO Bioscience, Inc. | 8.45 Million USD | 195.159% |
| Telesis Bio, Inc. | 32.63 Million USD | 124.642% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -221.406% |
| Varex Imaging Corporation | 316.9 Million USD | 102.538% |
| Quipt Home Medical Corp. | 81.73 Million USD | 109.839% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -189.073% |
| Pulmonx Corporation | -42.36 Million USD | 81.015% |
| Dynatronics Corporation | 6.2 Million USD | 229.625% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -87.154% |
| Semler Scientific, Inc. | -57.13 Million USD | 85.923% |
| InMode Ltd. | -135.39 Million USD | 94.06% |
| Bruker Corporation | 891.3 Million USD | 100.902% |
| Cytosorbents Corporation | 4.18 Million USD | 292.3% |
| DexCom, Inc. | 2.02 Billion USD | 100.397% |
| Align Technology, Inc. | -840.47 Million USD | 99.043% |
| Viveve Medical, Inc. | -13.81 Million USD | 41.779% |
| ZimVie Inc. | 450.41 Million USD | 101.785% |
| Movano Inc. | -5.86 Million USD | -37.095% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 94.019% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -1296.746% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 505.313% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 102.254% |
| Profound Medical Corp. | -18.17 Million USD | 55.761% |
| Insulet Corporation | 798.1 Million USD | 101.008% |
| enVVeno Medical Corporation | -2.21 Million USD | -262.579% |
| Surmodics, Inc. | -12.01 Million USD | 33.061% |
| iCAD, Inc. | -21.2 Million USD | 62.082% |
| Nuwellis, Inc. | -2.81 Million USD | -185.278% |
| Biotricity, Inc. | 23.09 Million USD | 134.825% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 108.587% |
| Aethlon Medical, Inc. | -4.5 Million USD | -78.645% |
| InspireMD, Inc. | -8.04 Million USD | 0.037% |
| PAVmed Inc. | 29.08 Million USD | 127.649% |
| BIOLASE, Inc. | 11.34 Million USD | 170.892% |
| Beyond Air, Inc. | 6.22 Million USD | 229.106% |
| FONAR Corporation | -14.66 Million USD | 45.163% |
| AxoGen, Inc. | 32.26 Million USD | 124.924% |
| Vivani Medical, Inc. | 42 Thousand USD | 19247.619% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 24.545% |
| Inari Medical, Inc. | -7.16 Million USD | -12.303% |
| UFP Technologies, Inc. | 40.77 Million USD | 119.723% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 362.072% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -68.549% |
| Tenon Medical, Inc. | -1.25 Million USD | -540.797% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -5.732% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 32.569% |
| AdaptHealth Corp. | 2.21 Billion USD | 100.363% |
| Sintx Technologies, Inc. | 905 Thousand USD | 988.619% |
| NanoVibronix, Inc. | -3.27 Million USD | -145.333% |
| Quanterix Corporation | -132.95 Million USD | 93.951% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -189.073% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 64.042% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 101.067% |
| TransMedics Group, Inc. | 121.13 Million USD | 106.639% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 69.282% |
| NeuroMetrix, Inc. | -1.49 Million USD | -439.344% |
| Hyperfine, Inc. | -75.61 Million USD | 89.365% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 105.284% |
| Biomerica, Inc. | -3.38 Million USD | -137.578% |
| Bone Biologics Corporation | -3.02 Million USD | -165.713% |
| AVITA Medical, Inc. | -26.23 Million USD | 69.342% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -337.443% |
| Silk Road Medical, Inc | 64.42 Million USD | 112.483% |